Michael Maris

Jun 12, 2024 | gatehouselaw.co.uk | Michael Maris |Joanne Charsley |Ashley Allen

Chohan v Ved and others [2024] EWHC 739 (Ch)There were two claims before the Court:Mrs Chohan’s derivative claim under the Companies Act 2006 (‘CA 2006’) on behalf of Nexbell Limited (‘the Company’), alleging breaches by Mr Ved of the duties he owed to the Company as its (at the material time) sole director.

May 30, 2024 | mondaq.com | Michael Maris

GC Gatehouse Chambers More Gatehouse Chambers (formerly Hardwicke) is a leading commercial chambers which specialises in arbitration and all forms of ADR, commercial dispute resolution, construction, insolvency, restructuring and company, insurance, professional liability and property disputes. It also has niche specialisms in clinical negligence and personal injury as well as private client work.

May 28, 2024 | lexology.com | Michael Maris

Chohan v Ved and others [2024] EWHC 739 (Ch)There were two claims before the Court:Mrs Chohan’s derivative claim under the Companies Act 2006 (‘CA 2006’) on behalf of Nexbell Limited (‘the Company’), alleging breaches by Mr Ved of the duties he owed to the Company as its (at the material time) sole director.

Feb 1, 2023 | onclive.com | Michael Maris

Michael Maris, MD, member physician, director of research, Colorado Blood Cancer Institute, partner, Sarah Cannon Research Institute, discusses key efficacy and safety data from the phase 2 OUTREACH trial (NCT03744676) in diffuse large B-cell lymphoma (DLBCL).